Hematopoietic Stem Cell Transplantation in Clinical Practice by Jennifer Treleaven, and A. J. Barrett Softcover - 512 pages Shipped in CLICK HERE Cat.# EL-HEM1 $231.65 BUY Published:  2008   ISBN:  9780443101472

PART 1. SETTING THE SCENE Introduction. Essential biology of stem cell transplantation

PART 2. STEM CELL TRANSPLANTATION AS DISEASE THERAPY Allogeneic transplantation in acute myeloid leukaemia. Stem cell transplantation for chronic myeloid leukaemia. Acute lymphoblastic leukemia in adults. Childhood leukemias. The myelodysplastic syndromes. Stem cell transplantation for myeloma. Hodgkin’s disease and non-Hodgkin's lymphoma. Chronic lymphocytic leukaemia. Stem cell transplantation for solid tumors in childhood. Hematopoietic stem cell transplantation in the treatment of breast cancer. Hematopoietic stem cell transplantation for solid tumors in adults. Germ cell tumors. Primary immunodeficiency diseases. Acquired aplastic anemia and Fanconi anemia. Stem cell transplantation for thalassaemia and sickle cell disease. Lysosomes and lysosomal function. Hematopoietic stem cell transplantation for autoimmune disorders

PART 3. PREPARATION FOR TRANSPLANT Patient selection: preliminary interview, screening and selecting a donor. Stem cell donor registries. Cord blood banks and umbilical cord blood transplantation in children and adults. HLA matching, compatibility testing and donor selection. Collection and processing of marrow and blood hematopoietic progenitor/stem cells. Vascular access. High-dose regimens for autologous stem cell transplantation. Myeloablative conditioning regimens for allogeneic transplantation. Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation. Transplants from unrelated or mismatched family donors. Management of the older patient

PART 4. POST-TRANSPLANT CARE Transfusion medicine support for hematopoietic stem cell transplantation. The transplant pharmacopoeia. Nutrition support. Barrier precautions, prophylaxis and neutropenic fever. Re-immunization after hematopoietic stem cell transplantation. Psychological and supportive care issues in the transplant setting.

PART 5. MANAGEMENT OF POST-TRANSPLANT COMPLICATIONS Graft failure. Acute graft-versus-host disease. Chronic graft-versus-host disease. Management of relapse and minimal residual disease after stem cell allografting. Bacterial infections. Viral infections post-transplant. Fungal infections post-transplantation. Parasitic infections. Multiple organ failure - intensive care after stem cell transplantation. Late effects after allogeneic stem cell transplantation.

PART 6. THE WIDER PERSPECTIVE Starting a hemopoietic stem cell transplant unit. Ethical and Legal Considerations in Stem Cell Transplantation. How to build and use a stem cell transplant database. Blood and Marrow Transplant Organizations. Stem cell transplantation - future

Evidence-Based Hematology by Mark Crowther Hardcover - 440 pages Shipped in CLICK HERE Cat.# JW-HEM1 $258.20 BUY Published:  2008   ISBN:  9781405157476

This unique new book uses a series of focussed questions, comprehensive literature evaluations and structured grades of recommendation to provide evidence for the treatment of hematological disorders, both malignant and benign. With contributions from leading international experts who have a real understanding of evidence-based medicine the book provides comprehensive reviews accompanied by clinical commentaries and recommendations on the best treatment regimes to adopt for individual patients.

The book is split into two sections: the first examines the methodology underlying evidence based practice, and the second concentrates on the clinical practice of hematology, providing current "best evidence" to guide practice in a series of well-defined clinical situations.

This clinical reference is an invaluable source of evidence-based information distilled into guidance for clinical practice which will be welcomed by practitioners, trainees and associated health professionals.

Table of Contents:

About the Contributors
Preface

Part I: A Guide to the Evidence

1. Rating the quality of evidence and making recommendations
2. An overview of systematic reviews
3. Interpreting results of clinical research
4. Finding the evidence
5. Applying EBM in clinical practice
6. Using evidence to guide the diagnosis of disease

Part II

7. Diagnosis of Deep Vein Thrombosis
8. Diagnosis of Pulmonary Embolism
9. Initial Therapy of Deep Vein Thrombosis and Pulmonary Embolism
10. Long-term Anticoagulation in Venous Thromboembolism
11. Thrombolytic Therapy for Deep Vein Thrombosis and Pulmonary Embolism
12. Inferior Vena Cava Interruption
13. Management of Venous Thromboembolism in Pregnancy
14. Pediatric Thrombosis
15. Bridging Anticoagulation in Patients who Require
16. Evidence-based approach to the diagnosis and management of thrombotic thrombocytopenic purpura
17. Diagnosis and Management of Disseminated Intravascular Coagulation
18. Diagnosis and Management of Hereditary Bleeding Disorders
19. Diagnosis and Management of Acquired Bleeding Disorders
20. Diagnosis and Management of Heparin-Induced Thrombocytopenia
21. Management of Antiphospholipid Antibody Syndrome

Part III

22. Clinical Questions in iron overload
23. Aplastic Anemia
24. Acquired Anemias
25. Immune thrombocytopenic purpura
26. Neutropenia
27. Hypereosinophilia
28. Porphyrias
29. Membrane and Enzyme Abnormalities of the Erythrocyte
30. Sickle cell disease
31. Evidence-based treatment of thalassemia major

Part IV

32. Acute Lymphoblastic Leukemia in Adults
33. Acute Myeloblastic Leukemia in Adults
34. Acute Myeloid Leukemia in Adults
35. Current Areas of Controversy in the Treatment of Patients
36. Chronic Lymphocytic Leukemia
37. Chronic Myelocytic Leukemia
38. Burkitt's Lymphoma
39. Primary Central Nervous System Lymphoma
40. Diffuse Large B-cell Lymphoma
41. Follicular Lymphoma
42. Lymphoblastic Lymphoma
43. Mantle Cell Lymphoma
44. Peripheral T-cell Lymphoma
45. Classical Hodgkin Lymphoma
46. Nodular Lymphocyte Predominant Hodgkin Lymphoma
47. Essential Thrombocythemia
48. Management of Patients with Polycythemia Vera
49. Multiple Myeloma
50. Waldenstroms Macroglobulinemia
51. Use of Hematopoietic Growth Factors for Hematologic Malignancies

Index

Consultative Hemostasis and Thrombosis by Craig Kitchens, Barbara Alving, and Craig Kessler Hardcover - 800 pages Shipped in CLICK HERE Cat.# EL-HEM2 $251.80 BUY Published:  2007    ISBN:  9781416024019

Effectively and efficiently diagnose and manage today's full range of clotting and bleeding disorders using clinical case studies that demonstrate real-world problems and solutions! For each condition examined, you'll review concise descriptions of its associated symptoms, along with laboratory findings, diagnosis, differential diagnosis, and treatment - all the clinical guidance you need - at your fingertips. It's the ideal real-life reference tool for busy physicians.

A reader-friendly design, coupled with nearly 385 illustrations and at-a-glance tables - many new to this edition - equip you to quickly locate the guidance you need.

Abundant laboratory protocols enable you to select and interpret lab tests more easily.

Table of Contents:

Part I: General Information
CHAPTER 1: The Consultative Process
CHAPTER 2: A Systematic Approach to the Bleeding Patient: Correlation of Clinical Symptoms and Signs with Laboratory Testing
CHAPTER 3: Endothelium

Part II: Hemorrhagic Processes
CHAPTER 4: Hemophilia A and B
CHAPTER 5: Less Common Congenital Disorders of Hemostasis
CHAPTER 6: Non-hemophilic inhibitors of coagulation
CHAPTER 7: von Willebrand Disease
CHAPTER 8: General aspects of thrombocytopenia, platelet transfusions and platelet growth factors CHAPTER 9: Immune Thrombocytopenic Purpura
CHAPTER 10:Congenital and Acquired Disorders of Platelet Function and Number
CHAPTER 11: Purpura and Other Hematovascular Disorders
CHAPTER 12: Disseminated Intravascular Coagulation
CHAPTER 13: The cross-talk of inflammation and coagulation in infectious disease and their value in disseminated intravascular coagulation

Part III: Thrombotic Processes
CHAPTER 14: Thrombophilia: Clinical and Laboratory Assessment and Management
CHAPTER 15: Deep Vein Thrombosis and Pulmonary Embolism
CHAPTER 16: Venous Thromboses at Unusual Sites
CHAPTER 17: Prevention, Diagnosis, and Treatment of the Postphlebitic Syndrome
CHAPTER 18: Thrombocytosis: essential thrombocythemia vs. reactive etiologies
CHAPTER 19: The Antiphospholipid Syndrome: Clinical Presentation, Diagnosis, and Patient Management
CHAPTER 20: Hemostatic aspects of cardiovascular medicine
CHAPTER 21: Risk factors for arterial thrombosis
CHAPTER 22: Peripheral Arterial Disease
CHAPTER 23: Thrombosis and Cancer
CHAPTER 24: Thrombotic Thrombocytopenic Purpura
CHAPTER 25: Heparin-Induced Thrombocytopenia

Part IV: Therapeutic Measures
CHAPTER 26: Antithrombotic Agents
CHAPTER 27: Blood Component And Pharmacologic Therapy of Hemostatic Disorders
CHAPTER 28 : Thrombolytic Therapy
CHAPTER 29: Topical Hemostatic Agents for Localized Bleeding
CHAPTER 30: Therapeutic Apheresis
CHAPTER 31: Vena Cava Filters
CHAPTER 32: Thrombosis Related to Venous Access Devices
CHAPTER 33: Dietary Supplements and Hemostasis

Part V: Issues Specific to Women
CHAPTER 34: Thrombotic Risk of Contraceptives and Other Hormonal Therapies
CHAPTER 35: Management of Bleeding Disorders in Pregnancy
CHAPTER 36: Management of thrombophilia and APLS during pregnancy

Part VI: Special Issues
CHAPTER 37: Surgery and Hemostasis
CHAPTER 38: Anticoagulation in the Perioperative Period
CHAPTER 39: Hemostasis Alterations in Liver Disease and Liver Transplantation
CHAPTER 40: Outpatient Anticoagulant Therapy
CHAPTER 41: Point of Care Testing for Hemostatic Disorders
CHAPTER 42: Prevention and Treatment of Venous Thromboembolism in Neurologic and Neurosurgical Patients
CHAPTER 43: Hematologic Interventions for Acute Central Nervous System Disease
CHAPTER 44: Atrial Septal Abnormalities and Cryptogenic Stroke
CHAPTER 45: Pulmonary Hypertension: Thrombotic and Non-Thrombotic in Origin
CHAPTER 46:Hemorrhage Control and Thrombosis Following Severe Injury
CHAPTER 47:Hemostatic Aspects of Sickle Cell Disease
CHAPTER 48: Anticoagulation for Atrial Fibrillation and Prosthetic Cardiac Valves

ABC of Clinical Haematology 3E by Drew Provan Softcover - 112 pages Shipped in CLICK HERE Cat.# JW-HEM2 $ 54.50 BUY Published:  2007   ISBN:  9781405153539

This ABC has established itself as a popular introduction to Clinical Haematology, relevant both for postgraduate students and primary care practitioners. Now in its third edition, the ABC of Clinical Haematology has been thoroughly revised, featuring the latest treatments for leukaemia, antithrombotics and drugs for lymphoma and covering the latest advances in haematology and bone marrow transplantation.

With each chapter written by specialists in their respective fields, this is an ideal basic text for general practice and hospital staff with patients who have blood related problems, in particular GPs, haematology nurses, junior doctors, haematologists, and trainees in haematology.

Table of Contents:

1. Iron Deficiency Anaemia
2. Macrocytic Anaemias
3. The Hereditary Anaemias
4. Polycythaemia, Essential Thrombocythaemia and Myelofibrosis
5. Chronic Myeloid Leukaemia
6. The Acute Leukaemias
7. Platelet Disorders
8. The Myelodysplastic Syndromes
9. Multiple Myeloma and Related Conditions
10. Bleeding Disorders, Thrombosis and Anticoagulation
11. Lymphoproliferative Disorders Including Chronic Lymphocytic Leukaemia
12. Stem Cell Transplantation
13. Haematological Disorders at the Extremes of Life
14. Haematological Emergencies
15. The Future of Haematology: the Impact of Molecular Biology and Gene Therap

Index

Modern Hematology, Biology and Clinical Management by Reinhold Munker, Erhard Hiller, Jonathan Glass, and Ronald Paquette Hardcover - 250 pages Shipped in CLICK HERE Cat.# DA-HEM1 $169.05 BUY Published:  2007   ISBN:  9781588295576

Reinhold Munker and his distinguished colleagues have updated and expanded Modern Hematology: Biology and Clinical Management, now in its second edition, to reflect the major advances in the understanding, diagnosis, and treatment of blood disorders. Modern Hematology: Biology and Clinical Management, Second Edition describes the latest clinical and scientific developments, including molecular studies used to diagnose a variety of hematological disorders and guide their treatment. Targeted and molecular therapies are discussed in detail, including kinase inhibitors in myeloproliferative disorders and humanized monoclonal antibodies. The use of peripheral blood and umbilical cord blood stem cells for transplantation is described, as well as the rationale and indications for non-myeloablative transplantation, emphasizing the preferability of immunotherapy over cytotoxic chemotherapy.

Modern Hematology: Biology and Clinical Management, Second Edition brings together facts, concepts, and protocols important for the practice of hematology. In 23 chapters, all major blood diseases are covered, as well as rare diseases that are of scientific interest. The first two chapters introduce the reader to the scientific basis of blood disorders. As in the previous edition, each chapter is illustrated by tables, figures, and a selection of color plates. Experts in pediatric hematology, myeloma, blood transfusion, hemoglobinopathies, pharmacology, and infectious diseases have expanded the scope of Modern Hematology.

Comprehensive and informative, Modern Hematology: Biology and Clinical Management, Second Edition is an invaluable resource for medical students, hematology trainees, residents, nurses, nurse practitioners, and physicians in other specialties treating patients with benign and malignant blood disorders.